Topco Scientific Co.,Ltd.
TWSE:5434.TW
280 (TWD) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 49,261.433 | 52,978.215 | 42,668.966 | 36,167.994 | 31,700.516 | 28,861.199 | 23,781.012 | 22,629.436 | 19,078.87 | 18,092.281 | 15,554.749 | 16,285.679 | 15,927.661 | 14,664.596 | 10,197.132 | 14,464.387 | 14,967.055 | 8,721.319 |
| Cost of Revenue
| 43,183.109 | 46,452.851 | 37,456.762 | 31,863.244 | 27,781.703 | 25,458.229 | 20,841.04 | 19,709.757 | 16,642.515 | 15,925.1 | 13,591.684 | 14,358.182 | 13,972.969 | 13,099.478 | 9,210.776 | 12,939.443 | 13,349.804 | 7,342.436 |
| Gross Profit
| 6,078.324 | 6,525.364 | 5,212.204 | 4,304.75 | 3,918.813 | 3,402.97 | 2,939.972 | 2,919.679 | 2,436.355 | 2,167.181 | 1,963.065 | 1,927.497 | 1,954.692 | 1,565.118 | 986.356 | 1,524.944 | 1,617.251 | 1,378.883 |
| Gross Profit Ratio
| 0.123 | 0.123 | 0.122 | 0.119 | 0.124 | 0.118 | 0.124 | 0.129 | 0.128 | 0.12 | 0.126 | 0.118 | 0.123 | 0.107 | 0.097 | 0.105 | 0.108 | 0.158 |
| Reseach & Development Expenses
| 117.479 | 156.411 | 101.172 | 100.23 | 77.361 | 22.353 | 5.517 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1,430.119 | 1,521.832 | 1,239.157 | 1,007.774 | 885.021 | 879.256 | 822.186 | 770.275 | 640.61 | 571.911 | 489.264 | 433.831 | 503.998 | 414.439 | 293.071 | 375.354 | 387.582 | 333.977 |
| Selling & Marketing Expenses
| 1,660.981 | 1,617.562 | 1,320.25 | 1,135.327 | 1,111.36 | 981.238 | 901.335 | 786.108 | 727.352 | 678.714 | 587.856 | 600.875 | 540.593 | 551.068 | 415.216 | 646.296 | 433.923 | 420.654 |
| SG&A
| 2,739.256 | 3,139.394 | 2,559.407 | 2,143.101 | 1,996.381 | 1,860.494 | 1,723.521 | 1,556.383 | 1,367.962 | 1,250.625 | 1,077.12 | 1,034.706 | 1,044.591 | 965.507 | 708.287 | 1,021.65 | 821.505 | 754.631 |
| Other Expenses
| 66.838 | 55.255 | 50.473 | -0.292 | -0.292 | 50.127 | 55.915 | 53.443 | -6.784 | 50.474 | 25.23 | -14.314 | 107.077 | 19.746 | -17.684 | -253.089 | -20.196 | -29.803 |
| Operating Expenses
| 2,856.735 | 3,295.805 | 2,660.579 | 2,243.039 | 2,073.45 | 1,882.555 | 1,726.186 | 1,557.628 | 1,367.962 | 1,250.625 | 1,077.12 | 1,034.706 | 1,044.591 | 965.507 | 708.287 | 1,021.65 | 821.505 | 754.631 |
| Operating Income
| 3,221.589 | 4,072.995 | 3,047.359 | 2,484.453 | 2,253.64 | 1,520.415 | 1,213.786 | 1,362.051 | 1,068.393 | 916.556 | 885.945 | 892.791 | 910.101 | 599.611 | 278.069 | 503.294 | 795.746 | 624.252 |
| Operating Income Ratio
| 0.065 | 0.077 | 0.071 | 0.069 | 0.071 | 0.053 | 0.051 | 0.06 | 0.056 | 0.051 | 0.057 | 0.055 | 0.057 | 0.041 | 0.027 | 0.035 | 0.053 | 0.072 |
| Total Other Income Expenses Net
| 187.058 | 168.736 | -7.51 | 74.973 | -45.441 | 274.562 | 104.419 | 144.738 | 145.375 | 134.782 | 92.654 | 95.867 | 240.639 | 178.531 | 154.427 | -87.164 | 0.828 | -54.249 |
| Income Before Tax
| 3,408.647 | 4,241.731 | 3,039.849 | 2,559.426 | 2,208.199 | 1,794.977 | 1,318.205 | 1,506.789 | 1,213.768 | 1,051.338 | 978.599 | 988.658 | 1,150.74 | 778.142 | 432.496 | 416.13 | 796.574 | 570.003 |
| Income Before Tax Ratio
| 0.069 | 0.08 | 0.071 | 0.071 | 0.07 | 0.062 | 0.055 | 0.067 | 0.064 | 0.058 | 0.063 | 0.061 | 0.072 | 0.053 | 0.042 | 0.029 | 0.053 | 0.065 |
| Income Tax Expense
| 1,027.554 | 1,166.556 | 738.889 | 494.101 | 491.246 | 413.389 | 319.499 | 302.518 | 254.307 | 189.425 | 179.49 | 182.519 | 220.552 | 120.404 | 87.864 | 107.747 | 181.971 | 136.355 |
| Net Income
| 2,835.024 | 3,018.478 | 2,294.458 | 2,068.35 | 1,722.308 | 1,404.675 | 997.625 | 1,203.347 | 958.221 | 859.697 | 797.569 | 804.405 | 952.453 | 659.994 | 344.067 | 307.778 | 614.534 | 438.831 |
| Net Income Ratio
| 0.058 | 0.057 | 0.054 | 0.057 | 0.054 | 0.049 | 0.042 | 0.053 | 0.05 | 0.048 | 0.051 | 0.049 | 0.06 | 0.045 | 0.034 | 0.021 | 0.041 | 0.05 |
| EPS
| 15.36 | 16.49 | 12.54 | 11.3 | 9.41 | 7.68 | 5.94 | 7.2 | 5.69 | 5.11 | 4.79 | 4.85 | 5.77 | 4.08 | 2.13 | 1.59 | 3.32 | 2.5 |
| EPS Diluted
| 15.03 | 16.29 | 12.45 | 11.21 | 9.35 | 7.62 | 5.91 | 7.16 | 5.64 | 5.07 | 4.65 | 4.75 | 5.7 | 4.05 | 2.12 | 1.58 | 3.32 | 2.5 |
| EBITDA
| 3,700.571 | 4,529.075 | 3,427.505 | 2,792.132 | 2,529.489 | 2,009.245 | 1,519.181 | 1,649.484 | 1,344.633 | 1,143.483 | 1,052.701 | 1,024.538 | 1,189.88 | 812.701 | 422.654 | 269.32 | 907.59 | 670.873 |
| EBITDA Ratio
| 0.075 | 0.085 | 0.08 | 0.077 | 0.08 | 0.07 | 0.064 | 0.073 | 0.07 | 0.063 | 0.068 | 0.063 | 0.075 | 0.055 | 0.041 | 0.019 | 0.061 | 0.077 |